{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T23:04:07Z","timestamp":1772751847443,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1177\/1933719114532845","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T10:51:08Z","timestamp":1398941468000},"page":"1171-1176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunohistochemical Detection of Promyelocytic Leukemia Zinc Finger and Histone 1.5 in Uterine Leiomyosarcoma and Leiomyoma"],"prefix":"10.1007","volume":"21","author":[{"given":"Mazdak","family":"Momeni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Kalir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Farag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisha Y.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linus","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Fishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Burstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"21091171_CR1","first-page":"561","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"Z Charles","year":"2002","unstructured":"Charles Z, Henry JN. Mesenchymal tumors of the uterus. In: Kurman RJ, Hedrick EL, Ronnett BM, eds. Blaustein\u2019s Pathology of the Female Genital Tract. New York: Springer Verlag; 2002:561."},{"issue":"3","key":"21091171_CR2","first-page":"414","volume":"83","author":"WH Parker","year":"1994","unstructured":"Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstetrics Gynecol. 1994;83(3):414\u2013448.","journal-title":"Obstetrics Gynecol"},{"issue":"3","key":"21091171_CR3","first-page":"399","volume":"76","author":"BL Harlow","year":"1986","unstructured":"Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Instit. 1986;76(3):399\u2013402.","journal-title":"J Natl Cancer Instit"},{"issue":"4","key":"21091171_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","volume":"162","author":"S Leibsohn","year":"1990","unstructured":"Leibsohn S, d\u2019Ablaing G, Mishell DR Jr, Schlaerth JB. Leio-myosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol. 1990;162(4): 968\u2013974.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"21091171_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ygyno.2009.09.023","volume":"116","author":"E D\u2019Angelo","year":"2010","unstructured":"D\u2019Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116(1):131\u2013139.","journal-title":"Gynecol Oncol"},{"key":"21091171_CR6","volume-title":"Pathology and Genetics of Tumours of the Breast and Female Genital Organs (WHO\/IARC Classification of Tumours)","author":"AT Fattaneh","year":"2003","unstructured":"Fattaneh AT, Peter D. Pathology and Genetics of Tumours of the Breast and Female Genital Organs (WHO\/IARC Classification of Tumours). Lyon: IARC Press; 2003."},{"issue":"4","key":"21091171_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5858\/2008-132-595-SMTOTU","volume":"132","author":"G Toledo","year":"2008","unstructured":"Toledo G, Oliva E. Smooth muscle tumors of the uterus: a practical approach. Arch Pathol Lab Med. 2008;132(4):595\u2013605.","journal-title":"Arch Pathol Lab Med"},{"issue":"7","key":"21091171_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","volume":"50","author":"CJ O\u2019Neill","year":"2007","unstructured":"O\u2019Neill CJ, McBride HA, Connolly LE, McCluggage WG. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential. Histopathology. 2007;50(7):851\u2013858.","journal-title":"Histopathology"},{"issue":"2","key":"21091171_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/PAP.0b013e3181cfb901","volume":"17","author":"PP Ip","year":"2010","unstructured":"Ip PP, Tse KY, Tam KF. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy. Adv Anat Pathol. 2010;17(2):91\u2013112.","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"21091171_CR10","first-page":"141","volume":"8","author":"T Hong","year":"2001","unstructured":"Hong T, Shimada Y, Uchida S, et al. Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma. Int J Mol Med. 2001;8(2):141\u2013148.","journal-title":"Int J Mol Med"},{"issue":"3","key":"21091171_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0940-2993(00)80028-7","volume":"52","author":"AB Moore","year":"2000","unstructured":"Moore AB, He H, Yoshida A, Rico PJ, Haseman JK, Dixon D. Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice. Exp Toxicol Pathol. 2000; 52(3):195\u2013200.","journal-title":"Exp Toxicol Pathol"},{"issue":"1","key":"21091171_CR12","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000080933","volume":"59","author":"H Gokaslan","year":"2005","unstructured":"Gokaslan H, Turkeri L, Kavak ZN, et al. Differential diagnosis of smooth muscle tumors utilizing p53, pTEN and Ki-67 expression with estrogen and progesterone receptors. Gynecol Obstet Invest. 2005;59(1):36\u201340.","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"21091171_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1006\/gyno.1997.4653","volume":"65","author":"KL Hall","year":"1997","unstructured":"Hall KL, Teneriello MG, Taylor RR, et al. Analysis of Ki-ras, p53, and MDM2 genes in uterine leiomyomas and leiomyosarcomas. Gynecol Oncol. 1997;65(2):330\u2013335.","journal-title":"Gynecol Oncol"},{"issue":"10","key":"21091171_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/modpathol.2009.96","volume":"22","author":"KR Mittal","year":"2009","unstructured":"Mittal KR, Chen F, Wei JJ, et al. Molecular and immunohisto-chemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod Pathol. 2009;22(10):1303\u20131311.","journal-title":"Mod Pathol"},{"issue":"3","key":"21091171_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/PGP.0b013e31815ea7f5","volume":"27","author":"L Chen","year":"2008","unstructured":"Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol. 2008;27(3):326\u2013332.","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"21091171_CR16","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/modpathol.2009.122","volume":"22","author":"CH Lee","year":"2009","unstructured":"Lee CH, Turbin DA, Sung YC, et al. A panel of antibodies to determine site of origin and malignancy in smooth muscle tumors. Mod Pathol. 2009;22(12):1519\u20131531.","journal-title":"Mod Pathol"},{"issue":"4","key":"21091171_CR17","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/sj.onc.1202375","volume":"18","author":"PL Yeyati","year":"1999","unstructured":"Yeyati PL, Shaknovich R, Boterashvili S, et al. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene. 1999;18(4):925\u2013934.","journal-title":"Oncogene"},{"issue":"10","key":"21091171_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/molehr\/gag080","volume":"9","author":"J Fahnenstich","year":"2003","unstructured":"Fahnenstich J, Nandy A, Milde-Langosch K, et al. Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells. Mol Hum Reprod. 2003;9(10):611\u2013623.","journal-title":"Mol Hum Reprod"},{"issue":"19","key":"21091171_CR19","doi-asserted-by":"publisher","first-page":"10255","DOI":"10.1073\/pnas.94.19.10255","volume":"94","author":"MH Koken","year":"1997","unstructured":"Koken MH, Reid A, Quignon F, et al. Leukemia-associated retinoic acid receptor alpha fusion partners, PML and PLZF, heterodimerize and colocalize to nuclear bodies. Proc Natl Acad Sci U S A. 1997;94(19):10255\u201310260.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"21091171_CR20","first-page":"323","volume":"12","author":"JD Licht","year":"1996","unstructured":"Licht JD, Shaknovich R, English MA, et al. Reduced and altered DNA-binding and transcriptional properties of the PLZF-retinoic acid receptor-alpha chimera generated in t(11;17)-associated acute promyelocytic leukemia. Oncogene. 1996;12(2):323\u2013336.","journal-title":"Oncogene"},{"issue":"7","key":"21091171_CR21","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.humpath.2012.11.014","volume":"44","author":"JF Hechtman","year":"2013","unstructured":"Hechtman JF, Beasley MB, Kinoshita Y, Ko HM, Hao K, Burstein DE. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study. Hum Pathol. 2013; 44(7):1400\u20131405.","journal-title":"Hum Pathol"},{"issue":"9","key":"21091171_CR22","doi-asserted-by":"publisher","first-page":"5533","DOI":"10.1128\/MCB.18.9.5533","volume":"18","author":"R Shaknovich","year":"1998","unstructured":"Shaknovich R, Yeyati PL, Ivins S, et al. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol. 1998;18(9):5533\u20135545.","journal-title":"Mol Cell Biol"},{"issue":"11","key":"21091171_CR23","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/onc.2009.455","volume":"29","author":"M Cheung","year":"2010","unstructured":"Cheung M, Pei J, Pei Y, Jhanwar SC, Pass HI, Testa JR. The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene. 2010;29(11):1633\u20131640.","journal-title":"Oncogene"},{"issue":"26","key":"21091171_CR24","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1038\/sj.onc.1207597","volume":"23","author":"F Felicetti","year":"2004","unstructured":"Felicetti F, Bottero L, Felli N, et al. Role of PLZF in melanoma progression. Oncogene. 2004;23(26):4567\u20134576.","journal-title":"Oncogene"},{"issue":"39","key":"21091171_CR25","doi-asserted-by":"publisher","first-page":"12978","DOI":"10.1021\/bi050623v","volume":"44","author":"K Hizume","year":"2005","unstructured":"Hizume K, Yoshimura SH, Takeyasu K. Linker histone H1 per se can induce three-dimensional folding of chromatin fiber. Biochemistry. 2005;44(39):12978\u20131289.","journal-title":"Biochemistry"},{"issue":"1\u20132","key":"21091171_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2008.11.003","volume":"431","author":"N Happel","year":"2009","unstructured":"Happel N, Doenecke D. Histone H1 and its isoforms: contribution to chromatin structure and function. Gene. 2009;431(1\u20132):1\u201312.","journal-title":"Gene"},{"issue":"2","key":"21091171_CR27","first-page":"84","volume":"62","author":"S Sato","year":"2012","unstructured":"Sato S, Takahashi S, Asamoto M, et al. Histone H1 expression in human prostate cancer tissues and cell lines. Pathology. international 2012;62(2):84\u201392.","journal-title":"Pathology"},{"issue":"5","key":"21091171_CR28","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1172\/JCI116453","volume":"91","author":"SJ Chen","year":"1993","unstructured":"Chen SJ, Zelent A, Tong JH, et al. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J Clin Invest. 1993;91(5):2260\u20132267.","journal-title":"J Clin Invest"},{"issue":"12","key":"21091171_CR29","doi-asserted-by":"publisher","first-page":"4544","DOI":"10.1182\/blood.V86.12.4544.bloodjournal86124544","volume":"86","author":"A Reid","year":"1995","unstructured":"Reid A, Gould A, Brand N, et al. Leukemia translocation gene, PLZF, is expressed with a speckled nuclear pattern in early hematopoietic progenitors. Blood. 1995;86(12):4544\u20134552.","journal-title":"Blood"},{"issue":"2","key":"21091171_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/76014","volume":"25","author":"M Barna","year":"2000","unstructured":"Barna M, Hawe N, Niswander L, et al. Plzf regulates limb and axial skeletal patterning. Nat Genet. 2000;25(2):166\u2013172.","journal-title":"Nat Genet"},{"issue":"3","key":"21091171_CR31","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ygyno.2011.11.009","volume":"124","author":"MM Leitao Jr","year":"2012","unstructured":"Leitao MM Jr, Hensley ML, Barakat RR, et al. Immunohisto-chemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leio-myosarcoma. Gynecol Oncol. 2012;124(3):558\u2013562.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"21091171_CR32","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/j.cell.2005.10.028","volume":"123","author":"Y Fan","year":"2005","unstructured":"Fan Y, Nikitina T, Zhao J, et al. Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation. Cell. 2005;123(7):1199\u20131212.","journal-title":"Cell"},{"issue":"3","key":"21091171_CR33","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0092-8674(00)80120-8","volume":"86","author":"X Shen","year":"1996","unstructured":"Shen X, Gorovsky MA. Linker histone H1 regulates specific gene expression but not global transcription in vivo. Cell. 1996;86(3): 475\u2013483.","journal-title":"Cell"},{"issue":"3","key":"21091171_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1139\/o01-098","volume":"79","author":"DA Hill","year":"2001","unstructured":"Hill DA. Influence of linker histone H1 on chromatin remodeling. Biochem Cell Biol. 2001;79(3):317\u2013324.","journal-title":"Biochem Cell Biol"},{"issue":"5677","key":"21091171_CR35","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1126\/science.1098096","volume":"304","author":"H Lee","year":"2004","unstructured":"Lee H, Habas R, Abate-Shen C. MSX1 cooperates with histone H1b for inhibition of transcription and myogenesis. Science. 2004;304(5677):1675\u20131678.","journal-title":"Science"},{"issue":"41","key":"21091171_CR36","doi-asserted-by":"publisher","first-page":"35347","DOI":"10.1074\/jbc.M111.281923","volume":"286","author":"JM Terme","year":"2011","unstructured":"Terme JM, Sese B, Millan-Arino L, et al. Histone H1 variants are differentially expressed and incorporated into chromatin during differentiation and reprogramming to pluripotency. J Biol Chem. 2011;286(41):35347\u201335357.","journal-title":"J Biol Chem"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114532845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719114532845","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719114532845\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719114532845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719114532845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:31:33Z","timestamp":1656811893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719114532845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["21091171"],"URL":"https:\/\/doi.org\/10.1177\/1933719114532845","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"30 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}